短腸症候群治療薬世界市場の発展状況と動向 2024-2030

QY Research > レポート一覧 > 薬品及びサプリメント > 短腸症候群治療薬世界市場の発展状況と動向 2024-2030

英文タイトル： Global Short Bowel Syndrome Drugs Market Insights, Forecast to 2030

レポートID：271231
発表時期：2024-04-25
訪問回数：240
ページ数：114
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：130
レポートカテゴリ：薬品及びサプリメント

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、短腸症候群治療薬の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に短腸症候群治療薬市場を分類しています。

本レポートでは世界の短腸症候群治療薬市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Emmaus Medical、Merck、Takeda、Ardelyx、Naia Pharmaceuticals、Nutrinia、OxThera、GLyPharma Therapeutic、Sancilio Pharmaceuticals、Zealand Pharma

レポートは短腸症候群治療薬の主要生産者を調査し、主要地域や国の消費状況も提供します。短腸症候群治療薬の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。

タイプ別市場セグメント：
Oral Short Bowel Syndrome Drugs
Tablet Short Bowel Syndrome Drugs

用途別の市場セグメント：
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

本レポートの詳細内容
本レポートは、世界の短腸症候群治療薬市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて短腸症候群治療薬市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。

一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の短腸症候群治療薬生産量、成長率、市場シェアを調査している。

二. 消費面では、短腸症候群治療薬の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの短腸症候群治療薬売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の短腸症候群治療薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本短腸症候群治療薬のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要

第1章：短腸症候群治療薬のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章：短腸症候群治療薬の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける短腸症候群治療薬の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章短腸症候群治療薬メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：短腸症候群治療薬の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：短腸症候群治療薬の主要メーカーの概要を提供し、製品の説明と仕様、短腸症候群治療薬の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：短腸症候群治療薬の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

概要

The global Short Bowel Syndrome Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Short Bowel Syndrome Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Short Bowel Syndrome Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Short Bowel Syndrome Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Short Bowel Syndrome Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Short Bowel Syndrome Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Sale Channel, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Short Bowel Syndrome Drugs sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Emmaus Medical, Merck, Takeda, Ardelyx, Naia Pharmaceuticals, Nutrinia, OxThera, GLyPharma Therapeutic and Sancilio Pharmaceuticals, etc.

Market Segmentation
By Company
Emmaus Medical
Merck
Takeda
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
GLyPharma Therapeutic
Sancilio Pharmaceuticals
Zealand Pharma

Segment by Type
Oral Short Bowel Syndrome Drugs
Tablet Short Bowel Syndrome Drugs

Segment by Sale Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Short Bowel Syndrome Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Short Bowel Syndrome Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Sale Channel and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Sale Channel and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Sale Channel, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Sale Channel and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Sale Channel and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Short Bowel Syndrome Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

総目録

1 Study Coverage
1.1 Short Bowel Syndrome Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral Short Bowel Syndrome Drugs
1.2.3 Tablet Short Bowel Syndrome Drugs
1.3 Market by Sale Channel
1.3.1 Global Short Bowel Syndrome Drugs Market Size Growth Rate by Sale Channel, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Short Bowel Syndrome Drugs Sales Estimates and Forecasts 2019-2030
2.2 Global Short Bowel Syndrome Drugs Revenue by Region
2.2.1 Global Short Bowel Syndrome Drugs Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Short Bowel Syndrome Drugs Revenue by Region (2019-2024)
2.2.3 Global Short Bowel Syndrome Drugs Revenue by Region (2025-2030)
2.2.4 Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2019-2030)
2.3 Global Short Bowel Syndrome Drugs Sales Estimates and Forecasts 2019-2030
2.4 Global Short Bowel Syndrome Drugs Sales by Region
2.4.1 Global Short Bowel Syndrome Drugs Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Short Bowel Syndrome Drugs Sales by Region (2019-2024)
2.4.3 Global Short Bowel Syndrome Drugs Sales by Region (2025-2030)
2.4.4 Global Short Bowel Syndrome Drugs Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 Competition by Manufactures
3.1 Global Short Bowel Syndrome Drugs Sales by Manufacturers
3.1.1 Global Short Bowel Syndrome Drugs Sales by Manufacturers (2019-2024)
3.1.2 Global Short Bowel Syndrome Drugs Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Short Bowel Syndrome Drugs in 2023
3.2 Global Short Bowel Syndrome Drugs Revenue by Manufacturers
3.2.1 Global Short Bowel Syndrome Drugs Revenue by Manufacturers (2019-2024)
3.2.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Short Bowel Syndrome Drugs Revenue in 2023
3.3 Global Key Players of Short Bowel Syndrome Drugs, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Short Bowel Syndrome Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Short Bowel Syndrome Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Short Bowel Syndrome Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Short Bowel Syndrome Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Short Bowel Syndrome Drugs Sales by Type
4.1.1 Global Short Bowel Syndrome Drugs Historical Sales by Type (2019-2024)
4.1.2 Global Short Bowel Syndrome Drugs Forecasted Sales by Type (2025-2030)
4.1.3 Global Short Bowel Syndrome Drugs Sales Market Share by Type (2019-2030)
4.2 Global Short Bowel Syndrome Drugs Revenue by Type
4.2.1 Global Short Bowel Syndrome Drugs Historical Revenue by Type (2019-2024)
4.2.2 Global Short Bowel Syndrome Drugs Forecasted Revenue by Type (2025-2030)
4.2.3 Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Short Bowel Syndrome Drugs Price by Type
4.3.1 Global Short Bowel Syndrome Drugs Price by Type (2019-2024)
4.3.2 Global Short Bowel Syndrome Drugs Price Forecast by Type (2025-2030)

5 Market Size by Sale Channel
5.1 Global Short Bowel Syndrome Drugs Sales by Sale Channel
5.1.1 Global Short Bowel Syndrome Drugs Historical Sales by Sale Channel (2019-2024)
5.1.2 Global Short Bowel Syndrome Drugs Forecasted Sales by Sale Channel (2025-2030)
5.1.3 Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2019-2030)
5.2 Global Short Bowel Syndrome Drugs Revenue by Sale Channel
5.2.1 Global Short Bowel Syndrome Drugs Historical Revenue by Sale Channel (2019-2024)
5.2.2 Global Short Bowel Syndrome Drugs Forecasted Revenue by Sale Channel (2025-2030)
5.2.3 Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2019-2030)
5.3 Global Short Bowel Syndrome Drugs Price by Sale Channel
5.3.1 Global Short Bowel Syndrome Drugs Price by Sale Channel (2019-2024)
5.3.2 Global Short Bowel Syndrome Drugs Price Forecast by Sale Channel (2025-2030)

6 US & Canada
6.1 US & Canada Short Bowel Syndrome Drugs Market Size by Type
6.1.1 US & Canada Short Bowel Syndrome Drugs Sales by Type (2019-2030)
6.1.2 US & Canada Short Bowel Syndrome Drugs Revenue by Type (2019-2030)
6.2 US & Canada Short Bowel Syndrome Drugs Market Size by Sale Channel
6.2.1 US & Canada Short Bowel Syndrome Drugs Sales by Sale Channel (2019-2030)
6.2.2 US & Canada Short Bowel Syndrome Drugs Revenue by Sale Channel (2019-2030)
6.3 US & Canada Short Bowel Syndrome Drugs Market Size by Country
6.3.1 US & Canada Short Bowel Syndrome Drugs Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Short Bowel Syndrome Drugs Sales by Country (2019-2030)
6.3.3 US & Canada Short Bowel Syndrome Drugs Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada

7 Europe
7.1 Europe Short Bowel Syndrome Drugs Market Size by Type
7.1.1 Europe Short Bowel Syndrome Drugs Sales by Type (2019-2030)
7.1.2 Europe Short Bowel Syndrome Drugs Revenue by Type (2019-2030)
7.2 Europe Short Bowel Syndrome Drugs Market Size by Sale Channel
7.2.1 Europe Short Bowel Syndrome Drugs Sales by Sale Channel (2019-2030)
7.2.2 Europe Short Bowel Syndrome Drugs Revenue by Sale Channel (2019-2030)
7.3 Europe Short Bowel Syndrome Drugs Market Size by Country
7.3.1 Europe Short Bowel Syndrome Drugs Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Short Bowel Syndrome Drugs Sales by Country (2019-2030)
7.3.3 Europe Short Bowel Syndrome Drugs Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia

8 China
8.1 China Short Bowel Syndrome Drugs Market Size
8.1.1 China Short Bowel Syndrome Drugs Sales (2019-2030)
8.1.2 China Short Bowel Syndrome Drugs Revenue (2019-2030)
8.2 China Short Bowel Syndrome Drugs Market Size by Sale Channel
8.2.1 China Short Bowel Syndrome Drugs Sales by Sale Channel (2019-2030)
8.2.2 China Short Bowel Syndrome Drugs Revenue by Sale Channel (2019-2030)

9 Asia (excluding China)
9.1 Asia Short Bowel Syndrome Drugs Market Size by Type
9.1.1 Asia Short Bowel Syndrome Drugs Sales by Type (2019-2030)
9.1.2 Asia Short Bowel Syndrome Drugs Revenue by Type (2019-2030)
9.2 Asia Short Bowel Syndrome Drugs Market Size by Sale Channel
9.2.1 Asia Short Bowel Syndrome Drugs Sales by Sale Channel (2019-2030)
9.2.2 Asia Short Bowel Syndrome Drugs Revenue by Sale Channel (2019-2030)
9.3 Asia Short Bowel Syndrome Drugs Sales by Region
9.3.1 Asia Short Bowel Syndrome Drugs Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Short Bowel Syndrome Drugs Revenue by Region (2019-2030)
9.3.3 Asia Short Bowel Syndrome Drugs Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India

10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Market Size by Sale Channel
10.2.1 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales by Sale Channel (2019-2030)
10.2.2 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Sale Channel (2019-2030)
10.3 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries

11 Company Profiles
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Information
11.1.2 Emmaus Medical Overview
11.1.3 Emmaus Medical Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Emmaus Medical Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Emmaus Medical Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Merck Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Takeda
11.3.1 Takeda Company Information
11.3.2 Takeda Overview
11.3.3 Takeda Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Takeda Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Takeda Recent Developments
11.4 Ardelyx
11.4.1 Ardelyx Company Information
11.4.2 Ardelyx Overview
11.4.3 Ardelyx Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Ardelyx Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ardelyx Recent Developments
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Company Information
11.5.2 Naia Pharmaceuticals Overview
11.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Naia Pharmaceuticals Recent Developments
11.6 Nutrinia
11.6.1 Nutrinia Company Information
11.6.2 Nutrinia Overview
11.6.3 Nutrinia Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Nutrinia Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Nutrinia Recent Developments
11.7 OxThera
11.7.1 OxThera Company Information
11.7.2 OxThera Overview
11.7.3 OxThera Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 OxThera Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 OxThera Recent Developments
11.8 GLyPharma Therapeutic
11.8.1 GLyPharma Therapeutic Company Information
11.8.2 GLyPharma Therapeutic Overview
11.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GLyPharma Therapeutic Recent Developments
11.9 Sancilio Pharmaceuticals
11.9.1 Sancilio Pharmaceuticals Company Information
11.9.2 Sancilio Pharmaceuticals Overview
11.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sancilio Pharmaceuticals Recent Developments
11.10 Zealand Pharma
11.10.1 Zealand Pharma Company Information
11.10.2 Zealand Pharma Overview
11.10.3 Zealand Pharma Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Zealand Pharma Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zealand Pharma Recent Developments

12 Industry Chain and Sales Channels Analysis
12.1 Short Bowel Syndrome Drugs Industry Chain Analysis
12.2 Short Bowel Syndrome Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Short Bowel Syndrome Drugs Production Mode & Process
12.4 Short Bowel Syndrome Drugs Sales and Marketing
12.4.1 Short Bowel Syndrome Drugs Sales Channels
12.4.2 Short Bowel Syndrome Drugs Distributors
12.5 Short Bowel Syndrome Drugs Customers

13 Market Dynamics
13.1 Short Bowel Syndrome Drugs Industry Trends
13.2 Short Bowel Syndrome Drugs Market Drivers
13.3 Short Bowel Syndrome Drugs Market Challenges
13.4 Short Bowel Syndrome Drugs Market Restraints

14 Key Findings in The Global Short Bowel Syndrome Drugs Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

表と図のリスト

List of Tables
    Table 1. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Oral Short Bowel Syndrome Drugs
    Table 3. Major Manufacturers of Tablet Short Bowel Syndrome Drugs
    Table 4. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Sale Channel, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Short Bowel Syndrome Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Short Bowel Syndrome Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Short Bowel Syndrome Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2019-2024)
    Table 9. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2025-2030)
    Table 10. Global Short Bowel Syndrome Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Short Bowel Syndrome Drugs Sales by Region (2019-2024) & (K Pcs)
    Table 12. Global Short Bowel Syndrome Drugs Sales by Region (2025-2030) & (K Pcs)
    Table 13. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2019-2024)
    Table 14. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2025-2030)
    Table 15. Global Short Bowel Syndrome Drugs Sales by Manufacturers (2019-2024) & (K Pcs)
    Table 16. Global Short Bowel Syndrome Drugs Sales Share by Manufacturers (2019-2024)
    Table 17. Global Short Bowel Syndrome Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Short Bowel Syndrome Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Short Bowel Syndrome Drugs Price by Manufacturers 2019-2024 (USD/Pcs)
    Table 21. Global Short Bowel Syndrome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Short Bowel Syndrome Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome Drugs as of 2023)
    Table 23. Global Key Manufacturers of Short Bowel Syndrome Drugs, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Short Bowel Syndrome Drugs, Product Offered and Application
    Table 25. Global Key Manufacturers of Short Bowel Syndrome Drugs, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Short Bowel Syndrome Drugs Sales by Type (2019-2024) & (K Pcs)
    Table 28. Global Short Bowel Syndrome Drugs Sales by Type (2025-2030) & (K Pcs)
    Table 29. Global Short Bowel Syndrome Drugs Sales Share by Type (2019-2024)
    Table 30. Global Short Bowel Syndrome Drugs Sales Share by Type (2025-2030)
    Table 31. Global Short Bowel Syndrome Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Short Bowel Syndrome Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Short Bowel Syndrome Drugs Revenue Share by Type (2019-2024)
    Table 34. Global Short Bowel Syndrome Drugs Revenue Share by Type (2025-2030)
    Table 35. Short Bowel Syndrome Drugs Price by Type (2019-2024) & (USD/Pcs)
    Table 36. Global Short Bowel Syndrome Drugs Price Forecast by Type (2025-2030) & (USD/Pcs)
    Table 37. Global Short Bowel Syndrome Drugs Sales by Sale Channel (2019-2024) & (K Pcs)
    Table 38. Global Short Bowel Syndrome Drugs Sales by Sale Channel (2025-2030) & (K Pcs)
    Table 39. Global Short Bowel Syndrome Drugs Sales Share by Sale Channel (2019-2024)
    Table 40. Global Short Bowel Syndrome Drugs Sales Share by Sale Channel (2025-2030)
    Table 41. Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2019-2024) & (US$ Million)
    Table 42. Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2025-2030) & (US$ Million)
    Table 43. Global Short Bowel Syndrome Drugs Revenue Share by Sale Channel (2019-2024)
    Table 44. Global Short Bowel Syndrome Drugs Revenue Share by Sale Channel (2025-2030)
    Table 45. Short Bowel Syndrome Drugs Price by Sale Channel (2019-2024) & (USD/Pcs)
    Table 46. Global Short Bowel Syndrome Drugs Price Forecast by Sale Channel (2025-2030) & (USD/Pcs)
    Table 47. US & Canada Short Bowel Syndrome Drugs Sales by Type (2019-2024) & (K Pcs)
    Table 48. US & Canada Short Bowel Syndrome Drugs Sales by Type (2025-2030) & (K Pcs)
    Table 49. US & Canada Short Bowel Syndrome Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Short Bowel Syndrome Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Short Bowel Syndrome Drugs Sales by Sale Channel (2019-2024) & (K Pcs)
    Table 52. US & Canada Short Bowel Syndrome Drugs Sales by Sale Channel (2025-2030) & (K Pcs)
    Table 53. US & Canada Short Bowel Syndrome Drugs Revenue by Sale Channel (2019-2024) & (US$ Million)
    Table 54. US & Canada Short Bowel Syndrome Drugs Revenue by Sale Channel (2025-2030) & (US$ Million)
    Table 55. US & Canada Short Bowel Syndrome Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Short Bowel Syndrome Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Short Bowel Syndrome Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Short Bowel Syndrome Drugs Sales by Country (2019-2024) & (K Pcs)
    Table 59. US & Canada Short Bowel Syndrome Drugs Sales by Country (2025-2030) & (K Pcs)
    Table 60. Europe Short Bowel Syndrome Drugs Sales by Type (2019-2024) & (K Pcs)
    Table 61. Europe Short Bowel Syndrome Drugs Sales by Type (2025-2030) & (K Pcs)
    Table 62. Europe Short Bowel Syndrome Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Short Bowel Syndrome Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Short Bowel Syndrome Drugs Sales by Sale Channel (2019-2024) & (K Pcs)
    Table 65. Europe Short Bowel Syndrome Drugs Sales by Sale Channel (2025-2030) & (K Pcs)
    Table 66. Europe Short Bowel Syndrome Drugs Revenue by Sale Channel (2019-2024) & (US$ Million)
    Table 67. Europe Short Bowel Syndrome Drugs Revenue by Sale Channel (2025-2030) & (US$ Million)
    Table 68. Europe Short Bowel Syndrome Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Short Bowel Syndrome Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Short Bowel Syndrome Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Short Bowel Syndrome Drugs Sales by Country (2019-2024) & (K Pcs)
    Table 72. Europe Short Bowel Syndrome Drugs Sales by Country (2025-2030) & (K Pcs)
    Table 73. China Short Bowel Syndrome Drugs Sales by Type (2019-2024) & (K Pcs)
    Table 74. China Short Bowel Syndrome Drugs Sales by Type (2025-2030) & (K Pcs)
    Table 75. China Short Bowel Syndrome Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Short Bowel Syndrome Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Short Bowel Syndrome Drugs Sales by Sale Channel (2019-2024) & (K Pcs)
    Table 78. China Short Bowel Syndrome Drugs Sales by Sale Channel (2025-2030) & (K Pcs)
    Table 79. China Short Bowel Syndrome Drugs Revenue by Sale Channel (2019-2024) & (US$ Million)
    Table 80. China Short Bowel Syndrome Drugs Revenue by Sale Channel (2025-2030) & (US$ Million)
    Table 81. Asia Short Bowel Syndrome Drugs Sales by Type (2019-2024) & (K Pcs)
    Table 82. Asia Short Bowel Syndrome Drugs Sales by Type (2025-2030) & (K Pcs)
    Table 83. Asia Short Bowel Syndrome Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Short Bowel Syndrome Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Short Bowel Syndrome Drugs Sales by Sale Channel (2019-2024) & (K Pcs)
    Table 86. Asia Short Bowel Syndrome Drugs Sales by Sale Channel (2025-2030) & (K Pcs)
    Table 87. Asia Short Bowel Syndrome Drugs Revenue by Sale Channel (2019-2024) & (US$ Million)
    Table 88. Asia Short Bowel Syndrome Drugs Revenue by Sale Channel (2025-2030) & (US$ Million)
    Table 89. Asia Short Bowel Syndrome Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Short Bowel Syndrome Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Short Bowel Syndrome Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Short Bowel Syndrome Drugs Sales by Region (2019-2024) & (K Pcs)
    Table 93. Asia Short Bowel Syndrome Drugs Sales by Region (2025-2030) & (K Pcs)
    Table 94. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales by Type (2019-2024) & (K Pcs)
    Table 95. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales by Type (2025-2030) & (K Pcs)
    Table 96. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales by Sale Channel (2019-2024) & (K Pcs)
    Table 99. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales by Sale Channel (2025-2030) & (K Pcs)
    Table 100. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Sale Channel (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Sale Channel (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales by Country (2019-2024) & (K Pcs)
    Table 106. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales by Country (2025-2030) & (K Pcs)
    Table 107. Emmaus Medical Company Information
    Table 108. Emmaus Medical Description and Major Businesses
    Table 109. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 110. Emmaus Medical Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Emmaus Medical Recent Developments
    Table 112. Merck Company Information
    Table 113. Merck Description and Major Businesses
    Table 114. Merck Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 115. Merck Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Merck Recent Developments
    Table 117. Takeda Company Information
    Table 118. Takeda Description and Major Businesses
    Table 119. Takeda Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 120. Takeda Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Takeda Recent Developments
    Table 122. Ardelyx Company Information
    Table 123. Ardelyx Description and Major Businesses
    Table 124. Ardelyx Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 125. Ardelyx Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Ardelyx Recent Developments
    Table 127. Naia Pharmaceuticals Company Information
    Table 128. Naia Pharmaceuticals Description and Major Businesses
    Table 129. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 130. Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Naia Pharmaceuticals Recent Developments
    Table 132. Nutrinia Company Information
    Table 133. Nutrinia Description and Major Businesses
    Table 134. Nutrinia Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 135. Nutrinia Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Nutrinia Recent Developments
    Table 137. OxThera Company Information
    Table 138. OxThera Description and Major Businesses
    Table 139. OxThera Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 140. OxThera Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. OxThera Recent Developments
    Table 142. GLyPharma Therapeutic Company Information
    Table 143. GLyPharma Therapeutic Description and Major Businesses
    Table 144. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 145. GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. GLyPharma Therapeutic Recent Developments
    Table 147. Sancilio Pharmaceuticals Company Information
    Table 148. Sancilio Pharmaceuticals Description and Major Businesses
    Table 149. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 150. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Sancilio Pharmaceuticals Recent Developments
    Table 152. Zealand Pharma Company Information
    Table 153. Zealand Pharma Description and Major Businesses
    Table 154. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 155. Zealand Pharma Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Zealand Pharma Recent Developments
    Table 157. Key Raw Materials Lists
    Table 158. Raw Materials Key Suppliers Lists
    Table 159. Short Bowel Syndrome Drugs Distributors List
    Table 160. Short Bowel Syndrome Drugs Customers List
    Table 161. Short Bowel Syndrome Drugs Market Trends
    Table 162. Short Bowel Syndrome Drugs Market Drivers
    Table 163. Short Bowel Syndrome Drugs Market Challenges
    Table 164. Short Bowel Syndrome Drugs Market Restraints
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Short Bowel Syndrome Drugs Product Picture
    Figure 2. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Short Bowel Syndrome Drugs Market Share by Type in 2023 & 2030
    Figure 4. Oral Short Bowel Syndrome Drugs Product Picture
    Figure 5. Tablet Short Bowel Syndrome Drugs Product Picture
    Figure 6. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Sale Channel, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Short Bowel Syndrome Drugs Market Share by Sale Channel in 2023 & 2030
    Figure 8. Hospital Pharmacies
    Figure 9. Retail Pharmacies
    Figure 10. Online Pharmacies
    Figure 11. Short Bowel Syndrome Drugs Report Years Considered
    Figure 12. Global Short Bowel Syndrome Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Short Bowel Syndrome Drugs Revenue 2019-2030 (US$ Million)
    Figure 14. Global Short Bowel Syndrome Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2019-2030)
    Figure 16. Global Short Bowel Syndrome Drugs Sales 2019-2030 ((K Pcs)
    Figure 17. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Short Bowel Syndrome Drugs Sales YoY (2019-2030) & (K Pcs)
    Figure 19. US & Canada Short Bowel Syndrome Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Short Bowel Syndrome Drugs Sales YoY (2019-2030) & (K Pcs)
    Figure 21. Europe Short Bowel Syndrome Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Short Bowel Syndrome Drugs Sales YoY (2019-2030) & (K Pcs)
    Figure 23. China Short Bowel Syndrome Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Short Bowel Syndrome Drugs Sales YoY (2019-2030) & (K Pcs)
    Figure 25. Asia (excluding China) Short Bowel Syndrome Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales YoY (2019-2030) & (K Pcs)
    Figure 27. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Short Bowel Syndrome Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Short Bowel Syndrome Drugs in the World: Market Share by Short Bowel Syndrome Drugs Revenue in 2023
    Figure 30. Global Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Short Bowel Syndrome Drugs Sales Market Share by Type (2019-2030)
    Figure 32. Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2019-2030)
    Figure 33. Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2019-2030)
    Figure 34. Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2019-2030)
    Figure 35. US & Canada Short Bowel Syndrome Drugs Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Short Bowel Syndrome Drugs Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2019-2030)
    Figure 38. US & Canada Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2019-2030)
    Figure 39. US & Canada Short Bowel Syndrome Drugs Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Short Bowel Syndrome Drugs Sales Share by Country (2019-2030)
    Figure 41. U.S. Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Short Bowel Syndrome Drugs Sales Market Share by Type (2019-2030)
    Figure 44. Europe Short Bowel Syndrome Drugs Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2019-2030)
    Figure 46. Europe Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2019-2030)
    Figure 47. Europe Short Bowel Syndrome Drugs Revenue Share by Country (2019-2030)
    Figure 48. Europe Short Bowel Syndrome Drugs Sales Share by Country (2019-2030)
    Figure 49. Germany Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 50. France Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 54. China Short Bowel Syndrome Drugs Sales Market Share by Type (2019-2030)
    Figure 55. China Short Bowel Syndrome Drugs Revenue Market Share by Type (2019-2030)
    Figure 56. China Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2019-2030)
    Figure 57. China Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2019-2030)
    Figure 58. Asia Short Bowel Syndrome Drugs Sales Market Share by Type (2019-2030)
    Figure 59. Asia Short Bowel Syndrome Drugs Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2019-2030)
    Figure 61. Asia Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2019-2030)
    Figure 62. Asia Short Bowel Syndrome Drugs Revenue Share by Region (2019-2030)
    Figure 63. Asia Short Bowel Syndrome Drugs Sales Share by Region (2019-2030)
    Figure 64. Japan Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 68. India Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2019-2030)
    Figure 72. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2019-2030)
    Figure 73. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Short Bowel Syndrome Drugs Sales Share by Country (2019-2030)
    Figure 75. Brazil Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Short Bowel Syndrome Drugs Revenue (2019-2030) & (US$ Million)
    Figure 80. Short Bowel Syndrome Drugs Value Chain
    Figure 81. Short Bowel Syndrome Drugs Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed

産業カテゴリー